NCT06108973

Brief Summary

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 31, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

October 31, 2023

Status Verified

October 1, 2023

Enrollment Period

12 months

First QC Date

October 26, 2023

Last Update Submit

October 26, 2023

Conditions

Chronic Obstructive Pulmonary Disease

Outcome Measures

Primary Outcomes (1)

  • Estimation of Volume consumption of Sevoflurane

    The consumption is expressed in Volume ml/kg

    8 weeks

Study Arms (2)

Normal Patients

Normal patients without any Lung Pathology for General Anesthesia

Device: Capnography

COPD patients

Established Chronic Obstructive Pulmonary Disease for General Anesthesia

Device: Capnography

Interventions

CapnographyDEVICE

To know the Co2 graph in COPD and Normal patients under General Anesthesia

COPD patientsNormal Patients

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Geography South East Asia-Sothern Peninsular INDIA' Soci Economic Mid Earning

You may qualify if:

  • Both Sex All Age Group Patient willing to give consent COPD patient

You may not qualify if:

  • Not willing to give consent Cancerous Lung Lung Lobectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Capnography

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Respiratory Function TestsDiagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Dr Manjunath, MD

    ESIC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Santhosh Kumar T N, BSc

CONTACT

6366470104tumakuru572102@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nursing Orderly

Study Record Dates

First Submitted

October 26, 2023

First Posted

October 31, 2023

Study Start

January 1, 2024

Primary Completion

December 30, 2024

Study Completion

March 30, 2025

Last Updated

October 31, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share